| ViraEpi1027 | Epstein barr virus (EBV) | Cp | NA | 11095 | 11095 | Hyper | 90% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1028 | Epstein barr virus (EBV) | Cp | NA | 11104 | 11104 | Hyper | 90% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1029 | Epstein barr virus (EBV) | Cp | NA | 11122 | 11122 | Hyper | 80% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1030 | Epstein barr virus (EBV) | Cp | NA | 11146 | 11146 | Hypo | 45% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1031 | Epstein barr virus (EBV) | Cp | NA | 11171 | 11171 | IntermedIate | 60% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1032 | Epstein barr virus (EBV) | Cp | NA | 11194 | 11194 | Hypo | 35% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1033 | Epstein barr virus (EBV) | Cp | NA | 11198 | 11198 | Hypo | 30% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1034 | Epstein barr virus (EBV) | Cp | NA | 11210 | 11210 | Hyper | 85% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1035 | Epstein barr virus (EBV) | Cp | NA | 11221 | 11221 | Hyper | 100% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1036 | Epstein barr virus (EBV) | Cp | NA | 11238 | 11238 | Hyper | 100% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1037 | Epstein barr virus (EBV) | Cp | NA | 11244 | 11244 | Hyper | 70% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1038 | Epstein barr virus (EBV) | Cp | NA | 11276 | 11276 | Hyper | 85% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1039 | Epstein barr virus (EBV) | Cp | NA | 11365 | 11365 | Hyper | 70% | PBMC | PBMC from patients | 20 samples from patient 3 | EBV-associated hemophagocytic syndrome (EBV-AHS) | Bisulphite PCR | 12767005 | | ViraEpi1040 | Epstein barr virus (EBV) | Cp | NA | 10956 | 10956 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1041 | Epstein barr virus (EBV) | Cp | NA | 10959 | 10959 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1042 | Epstein barr virus (EBV) | Cp | NA | 10985 | 10985 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1043 | Epstein barr virus (EBV) | Cp | NA | 10988 | 10988 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1044 | Epstein barr virus (EBV) | Cp | NA | 11030 | 11030 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1045 | Epstein barr virus (EBV) | Cp | NA | 11045 | 11045 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1046 | Epstein barr virus (EBV) | Cp | NA | 11063 | 11063 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1047 | Epstein barr virus (EBV) | Cp | NA | 11066 | 11066 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1048 | Epstein barr virus (EBV) | Cp | NA | 11095 | 11095 | Hypo | 16.66% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1049 | Epstein barr virus (EBV) | Cp | NA | 11104 | 11104 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1050 | Epstein barr virus (EBV) | Cp | NA | 11122 | 11122 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 | | ViraEpi1051 | Epstein barr virus (EBV) | Cp | NA | 11146 | 11146 | No methylation | 0% | PBMC | PBMC from patients | 6 samples from patient 4 | Infectious Mononucleosis (IM) | Bisulphite PCR | 12767005 |